Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia. - Lapchak,P.A.; Araujo,D.M.; Song,D.; Zivin,J.A. (Stroke, 2001)